Verano Holdings Operating Margin 2021-2025 | VRNO
Current and historical operating margin for Verano Holdings (VRNO) over the last 10 years. The current operating profit margin for Verano Holdings as of September 30, 2025 is -10.60%.
| Verano Holdings Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.83B | $0.07B | 8.88% |
| 2025-06-30 | $0.85B | $0.08B | 9.68% |
| 2025-03-31 | $0.87B | $0.08B | 9.57% |
| 2024-12-31 | $0.88B | $0.09B | 10.36% |
| 2024-09-30 | $0.90B | $0.10B | 11.04% |
| 2024-06-30 | $0.92B | $0.12B | 13.26% |
| 2024-03-31 | $0.93B | $0.13B | 13.41% |
| 2023-12-31 | $0.94B | $0.14B | 14.50% |
| 2023-09-30 | $0.93B | $0.13B | 13.59% |
| 2023-06-30 | $0.92B | $0.12B | 13.44% |
| 2023-03-31 | $0.91B | $0.09B | 10.06% |
| 2022-12-31 | $0.88B | $0.07B | 7.73% |
| 2022-09-30 | $0.87B | $0.07B | 8.09% |
| 2022-06-30 | $0.84B | $0.06B | 6.64% |
| 2022-03-31 | $0.82B | $0.06B | 7.09% |
| 2021-12-31 | $0.74B | $0.07B | 8.82% |
| 2021-09-30 | $0.60B | $0.07B | 10.83% |
| 2021-06-30 | $0.46B | $0.07B | 15.94% |
| 2021-03-31 | $0.31B | $0.09B | 28.76% |
| 2020-12-31 | $0.23B | $0.10B | 42.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.450B | $0.879B |
| Verano Holdings Corp. is a multi-state cannabis company. It produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano(TM), Avexia(TM), Encore(TM) and M?V(TM). Verano Holdings Corp. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $190.250B | 21.25 |
| EssilorLuxottica (ESLOY) | France | $141.053B | 0.00 |
| Stryker (SYK) | United States | $140.785B | 27.01 |
| Boston Scientific (BSX) | United States | $136.192B | 31.14 |
| Medtronic (MDT) | Ireland | $131.676B | 18.24 |
| Medline (MDLN) | United States | $59.144B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.791B | 0.00 |
| Agilent Technologies (A) | United States | $38.383B | 24.26 |
| ResMed (RMD) | United States | $37.110B | 24.78 |
| GE HealthCare Technologies (GEHC) | United States | $36.492B | 17.45 |
| Koninklijke Philips (PHG) | Netherlands | $27.828B | 18.18 |
| Terumo (TRUMY) | Japan | $19.515B | 22.05 |
| Insulet (PODD) | United States | $18.052B | 56.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.087B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.556B | 0.00 |
| Baxter (BAX) | United States | $10.214B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.023B | 28.85 |
| Demant (WILYY) | Denmark | $7.483B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.410B | 13.43 |
| Envista Holdings (NVST) | United States | $3.825B | 21.94 |
| BillionToOne (BLLN) | United States | $3.824B | 0.00 |
| ICU Medical (ICUI) | United States | $3.739B | 23.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.147B | 14.35 |
| Haemonetics (HAE) | United States | $3.079B | 13.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.007B | 0.00 |
| Neogen (NEOG) | United States | $2.230B | 48.81 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.960B | 39.45 |
| QuidelOrtho (QDEL) | United States | $1.878B | 12.07 |
| AtriCure (ATRC) | United States | $1.831B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.699B | 16.97 |
| Curaleaf Holdings (CURLF) | Canada | $1.472B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.459B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.368B | 19.80 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.075B | 319.00 |
| Capricor Therapeutics (CAPR) | United States | $1.056B | 0.00 |
| InMode (INMD) | Israel | $1.051B | 11.87 |
| Tilray Brands (TLRY) | Canada | $0.867B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.862B | 0.00 |
| Omeros (OMER) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.788B | 0.00 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 16.09 |
| Brainsway (BWAY) | Israel | $0.455B | 77.50 |
| Cerus (CERS) | United States | $0.446B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 24.24 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.228B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.222B | 130.67 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.199B | 0.00 |
| High Tide (HITI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.198B | 17.75 |
| Sanara MedTech (SMTI) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.76 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.54 |
| Exagen (XGN) | United States | $0.087B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.049B | 35.15 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 17.86 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Flora Growth (ZSTK) | United States | $0.008B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |